HEADER SIGNALING PROTEIN/PROTEIN BINDING 25-OCT-11 3UBW TITLE COMPLEX OF 14-3-3 ISOFORM EPSILON, A MLF1 PHOSPHOPEPTIDE AND A SMALL TITLE 2 FRAGMENT HIT FROM A FBDD SCREEN COMPND MOL_ID: 1; COMPND 2 MOLECULE: 14-3-3 PROTEIN EPSILON; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: DELTA C, UNP RESIDUES 1-234; COMPND 5 SYNONYM: 14-3-3E; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: MYELOID LEUKEMIA FACTOR 1; COMPND 9 CHAIN: P; COMPND 10 FRAGMENT: PHOSPHO- 14-3-3 BINDING MOTIF, UNP RESIDUES 29-42; COMPND 11 SYNONYM: MYELODYSPLASIA-MYELOID LEUKEMIA FACTOR 1; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: YWHAE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 OTHER_DETAILS: SYNTHETIC PEPTIDE KEYWDS ADAPTER PROTEIN, SIGNALING PROTEIN, SIGNALING PROTEIN-PROTEIN BINDING KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.MOLZAN,M.WEYAND,R.ROSE,C.OTTMANN REVDAT 3 06-NOV-24 3UBW 1 REMARK SEQADV LINK REVDAT 2 08-FEB-12 3UBW 1 JRNL REVDAT 1 25-JAN-12 3UBW 0 JRNL AUTH M.MOLZAN,M.WEYAND,R.ROSE,C.OTTMANN JRNL TITL STRUCTURAL INSIGHTS OF THE MLF1/14-3-3 INTERACTION. JRNL REF FEBS J. V. 279 563 2012 JRNL REFN ISSN 1742-464X JRNL PMID 22151054 JRNL DOI 10.1111/J.1742-4658.2011.08445.X REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 19794 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1042 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1463 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE SET COUNT : 77 REMARK 3 BIN FREE R VALUE : 0.2760 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1894 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 152 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.64000 REMARK 3 B22 (A**2) : -0.53000 REMARK 3 B33 (A**2) : 1.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.153 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.100 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.365 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2072 ; 0.026 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2818 ; 2.204 ; 1.992 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 266 ;14.320 ; 5.075 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 100 ;37.675 ;24.400 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 385 ;15.831 ;15.039 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;19.482 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 313 ; 0.236 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1563 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1275 ; 1.391 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2047 ; 2.457 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 797 ; 4.032 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 764 ; 6.528 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3UBW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-OCT-11. REMARK 100 THE DEPOSITION ID IS D_1000068559. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JUL-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : AL1/AL1 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS, XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20904 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 46.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.33600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.670 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: FOR CRYSTALLIZATION OF THE 14-3-3 REMARK 280 /MLF129-42 PEPTIDE COMPLEX, PROTEIN AND PEPTIDE WERE MIXED IN A REMARK 280 1:1.5 MOLAR RATIO IN 20 MM HEPES/NAOH PH 7.5, 2 MM MGCL2 AND 2 REMARK 280 MM 2-ME AND SET UP FOR CRYSTALLIZATION IN 0.1 M NA-CITRATE PH REMARK 280 5.6 AND 35% TERT-BUTANOL AT 4 C, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.96500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.96500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 39.01500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 40.65500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 39.01500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 40.65500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 40.96500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 39.01500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 40.65500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 40.96500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 39.01500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 40.65500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 40.96500 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -26 REMARK 465 SER A -25 REMARK 465 TYR A -24 REMARK 465 HIS A -23 REMARK 465 HIS A -22 REMARK 465 HIS A -21 REMARK 465 HIS A -20 REMARK 465 HIS A -19 REMARK 465 HIS A -18 REMARK 465 ASP A -17 REMARK 465 TYR A -16 REMARK 465 ASP A -15 REMARK 465 ILE A -14 REMARK 465 PRO A -13 REMARK 465 THR A -12 REMARK 465 THR A -11 REMARK 465 GLU A -10 REMARK 465 ASN A -9 REMARK 465 LEU A -8 REMARK 465 TYR A -7 REMARK 465 PHE A -6 REMARK 465 GLN A -5 REMARK 465 GLY A -4 REMARK 465 ALA A -3 REMARK 465 MET A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 SER A 233 REMARK 465 ASP A 234 REMARK 465 MET P 29 REMARK 465 ILE P 30 REMARK 465 GLY P 38 REMARK 465 ARG P 39 REMARK 465 ASP P 40 REMARK 465 LEU P 41 REMARK 465 LEU P 42 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 118 CE NZ REMARK 470 LYS A 142 CD CE NZ REMARK 470 GLU A 143 CD OE1 OE2 REMARK 470 GLU A 146 CG CD OE1 OE2 REMARK 470 ASP A 207 CG OD1 OD2 REMARK 470 LYS A 215 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG A 42 O HOH A 374 2.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 285 O HOH A 345 7445 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 19 78.07 -108.50 REMARK 500 HIS A 107 -56.09 -128.23 REMARK 500 SER A 213 14.56 -149.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TBU A 235 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TBU A 236 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TBU A 237 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TBU A 239 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 6SP A 240 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3UAL RELATED DB: PDB REMARK 900 SAME STRUCTURE WITHOUT FRAGMENT HIT REMARK 900 RELATED ID: 2BR9 RELATED DB: PDB REMARK 900 14-3-3 EPSILON IN COMPLEX WITH A CONSENSUS PEPTIDE DBREF 3UBW A 1 234 UNP P62258 1433E_HUMAN 1 234 DBREF 3UBW P 29 42 UNP P58340 MLF1_HUMAN 29 42 SEQADV 3UBW MET A -26 UNP P62258 EXPRESSION TAG SEQADV 3UBW SER A -25 UNP P62258 EXPRESSION TAG SEQADV 3UBW TYR A -24 UNP P62258 EXPRESSION TAG SEQADV 3UBW HIS A -23 UNP P62258 EXPRESSION TAG SEQADV 3UBW HIS A -22 UNP P62258 EXPRESSION TAG SEQADV 3UBW HIS A -21 UNP P62258 EXPRESSION TAG SEQADV 3UBW HIS A -20 UNP P62258 EXPRESSION TAG SEQADV 3UBW HIS A -19 UNP P62258 EXPRESSION TAG SEQADV 3UBW HIS A -18 UNP P62258 EXPRESSION TAG SEQADV 3UBW ASP A -17 UNP P62258 EXPRESSION TAG SEQADV 3UBW TYR A -16 UNP P62258 EXPRESSION TAG SEQADV 3UBW ASP A -15 UNP P62258 EXPRESSION TAG SEQADV 3UBW ILE A -14 UNP P62258 EXPRESSION TAG SEQADV 3UBW PRO A -13 UNP P62258 EXPRESSION TAG SEQADV 3UBW THR A -12 UNP P62258 EXPRESSION TAG SEQADV 3UBW THR A -11 UNP P62258 EXPRESSION TAG SEQADV 3UBW GLU A -10 UNP P62258 EXPRESSION TAG SEQADV 3UBW ASN A -9 UNP P62258 EXPRESSION TAG SEQADV 3UBW LEU A -8 UNP P62258 EXPRESSION TAG SEQADV 3UBW TYR A -7 UNP P62258 EXPRESSION TAG SEQADV 3UBW PHE A -6 UNP P62258 EXPRESSION TAG SEQADV 3UBW GLN A -5 UNP P62258 EXPRESSION TAG SEQADV 3UBW GLY A -4 UNP P62258 EXPRESSION TAG SEQADV 3UBW ALA A -3 UNP P62258 EXPRESSION TAG SEQADV 3UBW MET A -2 UNP P62258 EXPRESSION TAG SEQADV 3UBW GLY A -1 UNP P62258 EXPRESSION TAG SEQADV 3UBW SER A 0 UNP P62258 EXPRESSION TAG SEQRES 1 A 261 MET SER TYR HIS HIS HIS HIS HIS HIS ASP TYR ASP ILE SEQRES 2 A 261 PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA MET GLY SEQRES 3 A 261 SER MET ASP ASP ARG GLU ASP LEU VAL TYR GLN ALA LYS SEQRES 4 A 261 LEU ALA GLU GLN ALA GLU ARG TYR ASP GLU MET VAL GLU SEQRES 5 A 261 SER MET LYS LYS VAL ALA GLY MET ASP VAL GLU LEU THR SEQRES 6 A 261 VAL GLU GLU ARG ASN LEU LEU SER VAL ALA TYR LYS ASN SEQRES 7 A 261 VAL ILE GLY ALA ARG ARG ALA SER TRP ARG ILE ILE SER SEQRES 8 A 261 SER ILE GLU GLN LYS GLU GLU ASN LYS GLY GLY GLU ASP SEQRES 9 A 261 LYS LEU LYS MET ILE ARG GLU TYR ARG GLN MET VAL GLU SEQRES 10 A 261 THR GLU LEU LYS LEU ILE CYS CSO ASP ILE LEU ASP VAL SEQRES 11 A 261 LEU ASP LYS HIS LEU ILE PRO ALA ALA ASN THR GLY GLU SEQRES 12 A 261 SER LYS VAL PHE TYR TYR LYS MET LYS GLY ASP TYR HIS SEQRES 13 A 261 ARG TYR LEU ALA GLU PHE ALA THR GLY ASN ASP ARG LYS SEQRES 14 A 261 GLU ALA ALA GLU ASN SER LEU VAL ALA TYR LYS ALA ALA SEQRES 15 A 261 SER ASP ILE ALA MET THR GLU LEU PRO PRO THR HIS PRO SEQRES 16 A 261 ILE ARG LEU GLY LEU ALA LEU ASN PHE SER VAL PHE TYR SEQRES 17 A 261 TYR GLU ILE LEU ASN SER PRO ASP ARG ALA CYS ARG LEU SEQRES 18 A 261 ALA LYS ALA ALA PHE ASP ASP ALA ILE ALA GLU LEU ASP SEQRES 19 A 261 THR LEU SER GLU GLU SER TYR LYS ASP SER THR LEU ILE SEQRES 20 A 261 MET GLN LEU LEU ARG ASP ASN LEU THR LEU TRP THR SER SEQRES 21 A 261 ASP SEQRES 1 P 14 MET ILE ARG SER PHE SEP GLU PRO PHE GLY ARG ASP LEU SEQRES 2 P 14 LEU MODRES 3UBW CSO A 98 CYS S-HYDROXYCYSTEINE MODRES 3UBW SEP P 34 SER PHOSPHOSERINE HET CSO A 98 7 HET SEP P 34 10 HET TBU A 235 5 HET TBU A 236 5 HET TBU A 237 5 HET TBU A 238 5 HET TBU A 239 5 HET 6SP A 240 6 HETNAM CSO S-HYDROXYCYSTEINE HETNAM SEP PHOSPHOSERINE HETNAM TBU TERTIARY-BUTYL ALCOHOL HETNAM 6SP (3S)-PYRROLIDIN-3-OL HETSYN SEP PHOSPHONOSERINE HETSYN TBU 2-METHYL-2-PROPANOL FORMUL 1 CSO C3 H7 N O3 S FORMUL 2 SEP C3 H8 N O6 P FORMUL 3 TBU 5(C4 H10 O) FORMUL 8 6SP C4 H9 N O FORMUL 9 HOH *152(H2 O) HELIX 1 1 ASP A 3 ALA A 17 1 15 HELIX 2 2 ARG A 19 GLY A 32 1 14 HELIX 3 3 THR A 38 ASN A 72 1 35 HELIX 4 4 GLY A 75 HIS A 107 1 33 HELIX 5 5 HIS A 107 ALA A 112 1 6 HELIX 6 6 THR A 114 ALA A 136 1 23 HELIX 7 7 THR A 137 LEU A 163 1 27 HELIX 8 8 HIS A 167 ILE A 184 1 18 HELIX 9 9 SER A 187 GLU A 205 1 19 HELIX 10 10 LEU A 206 LEU A 209 5 4 HELIX 11 11 SER A 213 THR A 232 1 20 LINK C CYS A 97 N CSO A 98 1555 1555 1.33 LINK C CSO A 98 N ASP A 99 1555 1555 1.31 LINK C PHE P 33 N SEP P 34 1555 1555 1.32 LINK C SEP P 34 N GLU P 35 1555 1555 1.31 SITE 1 AC1 5 SER A 156 MET A 160 ALA A 174 HOH A 307 SITE 2 AC1 5 HOH A 365 SITE 1 AC2 3 SER A 156 MET A 160 TBU A 237 SITE 1 AC3 7 TYR A 181 ARG A 190 ARG A 193 LEU A 194 SITE 2 AC3 7 TBU A 236 HOH A 256 HOH A 268 SITE 1 AC4 3 LYS A 69 HOH A 245 HOH A 303 SITE 1 AC5 4 ASP A 216 LEU A 219 ILE A 220 PRO P 36 CRYST1 78.030 81.310 81.930 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012816 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012299 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012206 0.00000